0001209191-23-033106.txt : 20230531 0001209191-23-033106.hdr.sgml : 20230531 20230531161355 ACCESSION NUMBER: 0001209191-23-033106 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230531 DATE AS OF CHANGE: 20230531 EFFECTIVENESS DATE: 20230531 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALIMERA SCIENCES INC CENTRAL INDEX KEY: 0001267602 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200028718 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-478298 FILM NUMBER: 23981139 BUSINESS ADDRESS: STREET 1: 6310 TOWN SQUARE STREET 2: SUITE 400 CITY: ALPHARETTA STATE: GA ZIP: 30005 BUSINESS PHONE: 678-990-5740 MAIL ADDRESS: STREET 1: 6310 TOWN SQUARE STREET 2: SUITE 400 CITY: ALPHARETTA STATE: GA ZIP: 30005 D/A 1 primary_doc.xml X0708 D/A LIVE 0001267602 ALIMERA SCIENCES INC 6310 Town Square Suite 400 Alpharetta GA GEORGIA 30005 (678) 990-5740 DELAWARE None None Corporation true Richard S. Eiswirth, Jr. 6310 Town Square Suite 400 Alpharetta GA GEORGIA 30005 Executive Officer Director Philip Ashman 6310 Town Square Suite 400 Alpharetta GA GEORGIA 30005 Executive Officer David Holland 6310 Town Square Suite 400 Alpharetta GA GEORGIA 30005 Executive Officer Russell Skibsted 6310 Town Square Suite 400 Alpharetta GA GEORGIA 30005 Executive Officer Garheng Kong 6310 Town Square Suite 400 Alpharetta GA GEORGIA 30005 Director Daniel Myers 6310 Town Square Suite 400 Alpharetta GA GEORGIA 30005 Director Adam Morgan 6310 Town Square Suite 400 Alpharetta GA GEORGIA 30005 Director Erin Parsons 6310 Town Square Suite 400 Alpharetta GA GEORGIA 30005 Director Michael Kaseta 6310 Town Square Suite 400 Alpharetta GA GEORGIA 30005 Director Peter J. Pizzo III 6310 Town Square Suite 400 Alpharetta GA GEORGIA 30005 Director John Snisarenko 6310 Town Square Suite 400 Alpharetta GA GEORGIA 30005 Director Pharmaceuticals $25,000,001 - $100,000,000 06b true 0001209191-23-023829 2023-03-24 false true true true false 0 81000000 81000000 0 The amounts set forth in Item 13(a) and 13(b) represent a two tranche closing. The first tranche, consisting of $12,000,000 of securities closed on 03/24/2023 and the second tranche, consisting of $69,000,000 of securities closed on 05/17/2023. false 16 0 0 0 false Alimera Sciences Inc /s/ Richard S. Eiswirth, Jr. Richard S. Eiswirth, Jr. Chief Executive Officer 2023-05-31